Amylyx Pharmaceuticals Inc (AMLX)

Other Income/Expenses (Net)

$10.06M

TTM · Period ending: · USD

AMLX logo

AMLX Other Income/Expenses (Net)

Latest reported$10.06M
AMLX Other Income/Expenses (Net) (-$162.00K → $10.06M)
High-resolution chart · PNG

AMLX other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amylyx Pharmaceuticals Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
8,602,000
12,595,000
15,495,000
3,740,000
-5,243,000
-3,275,000
-162,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.